Eiry Roberts, Chief Medical Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 14,400 shares at $103.48 ($1.5M) on 2023-04-24, disclosed to the SEC on 2023-04-26.
Scheduled sale ($1.5M) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| NBIX | SELL | 2025-02-04 | $445K | — | Filing → |
| NBIX | SELL | 2024-02-15 | $296K | — | Filing → |
| NBIX | SELL | 2024-02-08 | $582K | — | Filing → |